Source LDPath, a part of the Source BioScience group, provides flexible cellular and digital pathology services to the NHS and private healthcare.
A market leader for histopathology services in the UK, Source LDPath supports NHS and private healthcare increase reporting capacities and clear backlogs of cellular and molecular diagnostic pathology samples. The company provides an end-to-end clinical healthcare service from histopathology, including digital pathology and AI, through to molecular diagnostics services, and hosts a significant and growing network of 280+ Specialist Consultant Pathologists.
The full range of diagnostic solutions will be showcased at Congress, with a focus this year on how digital pathology is accelerating the future of diagnostic reporting by improving workflow efficiency and enhancing patient care. The Source team will be available to discuss how our integrated services can support pathology departments in managing increasing workloads and delivering faster results.